GLP-1 Medications and Weight Regain After Stopping
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
GLP-1 Medications and Weight Regain After Stopping
-
ナレーター：
-
著者：
概要
GLP-1 medications like semaglutide and tirzepatide have changed how many people think about weight management. But what happens after stopping them is less often discussed—and often misunderstood.
In this episode, we look at what the evidence shows about weight regain after discontinuing GLP-1–based medications. You’ll hear how findings from systematic reviews and randomized trials compare continued treatment with stopping, and what those results suggest about longer-term patterns.
We also explore why this topic creates so much uncertainty. When a treatment works while it’s being used, it can shape expectations about what should happen afterward. That tension—between short-term results and longer-term outcomes—can make decisions feel more complicated.
This episode doesn’t tell you what to do. Instead, it offers a clear, evidence-informed view of what is known, what varies across studies, and what remains uncertain. So you can better understand how to interpret claims, expectations, and trade-offs around starting or stopping these medications.
📝 Full transcript, evidence, and this week’s clarity poll →
beyondthebuzzmedia.com